Literature DB >> 23117973

Letter to "Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients--a possible guide for efficient sleeve gastrectomy construction" Obesity Surgery (2012) 22:617-622. doi:10.1007/s11695-011-0585-9.

Fabiana A N Maksud, Alfredo J A Barbosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23117973     DOI： 10.1007/s11695-012-0809-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  5 in total

1.  Increased density of ghrelin-expressing cells in the gastric fundus and body in Prader-Willi syndrome.

Authors:  Yon Ho Choe; Sang Yong Song; Kyung-Hoon Paik; Yoo Joung Oh; Su-Hyun Chu; Sung Hee Yeo; Eun Kyung Kwon; Eun Mee Kim; Mee Yong Rha; Dong-Kyu Jin
Journal:  J Clin Endocrinol Metab       Date:  2005-06-14       Impact factor: 5.958

2.  Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients.

Authors:  Fabiana A N Maksud; Jairo S Alves; Marco T C Diniz; Alfredo J A Barbosa
Journal:  Eur J Endocrinol       Date:  2011-05-09       Impact factor: 6.664

3.  Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients--a possible guide for efficient sleeve gastrectomy construction.

Authors:  David Goitein; Doron Lederfein; Ronit Tzioni; Haim Berkenstadt; Moris Venturero; Moshe Rubin
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

4.  Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes.

Authors:  Seppo M Pöykkö; Eija Kellokoski; Sohvi Hörkkö; Heikki Kauma; Y Antero Kesäniemi; Olavi Ukkola
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

5.  Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.

Authors:  K Zwirska-Korczala; S J Konturek; M Sodowski; M Wylezol; D Kuka; P Sowa; M Adamczyk-Sowa; M Kukla; A Berdowska; J F Rehfeld; W Bielanski; T Brzozowski
Journal:  J Physiol Pharmacol       Date:  2007-03       Impact factor: 3.011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.